Search Product
Structure Search
Search
Online Support
-
Customer service
Advantage Products
Location: Industrial Info
Chinese scientist David Ho announced the AIDS major achievements
2014-08-02
来源：转载自第三方
The research team USA famous Chinese scientists David Ho announced the day before yesterday, developed a new drug, people in the future as long as a shot, there may be 3 months not infected with the AIDS virus. Researchers believe, the use of this drug can be developed AIDS vaccine before the transition scheme. To rely on daily take pills to prevent AIDS people, can also be used as alternative medicine.
Publish an AIDS conference in Boston this study, and has been published in "science" magazine web site USA. Known for his invention of the AIDS cocktail therapy David Ho said: "this study will try to give a great boost to the AIDS prevention."
Has to do the test on rhesus monkeys
David Ho refers to the drug called GSK744LA has not been tested on humans, but using rhesus monkeys proved efficacy, sufficient to maintain 3 to 4 months in the human body, so that the drug should be quarterly infusions.
In a 8 week experiment, researchers are at the beginning stage and fourth weeks in 8 rhesus monkeys the injection of a drug, and then use the similar to human AIDS virus SHIV (SHIV) against the rhesus macaque, attack once a week, at the end of the experiment 8 rhesus monkeys are well. In the experiment, injection of placebo in rhesus monkeys were infected.
Reduction of high risk infection rate
David Ho described it as a preventive medication treatment, different from the vaccine, it can effectively help the high risk individuals to reduce HIV infection probability, but also solve the previous treatment methods are difficult to adhere to the long-term problem.
For this new discovery, AIDS treatment expert, America California University in San Francisco City, Grant to "science" magazine said, it will change the rules of the game and the prevention of AIDS, "said study in my knowledge of AIDS prevention, this is the most exciting news". However, Johnson children's Hospital of Philadelphia American think, even 3 months a shot, to insist that there are difficulties, "the long run is not feasible.".
David Ho said, "AIDS vaccine is still very, very far away", so in the vaccine before development, this scheme can be used to "the middle of a transitional period". The research team with the GlaxoSmithKline Co in American conducting clinical trials, can be expected to obtain more safety data on the long-term drug next year. In addition, they also plan in populations at high risk for other countries in similar clinical research.
如果涉及转载授权，请联系我们。
